Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

TMI-1

🥰Excellent
Catalog No. T28985Cas No. 287403-39-8
Alias WAY-171318

TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.

TMI-1

TMI-1

🥰Excellent
Purity: 97.36%
Catalog No. T28985Alias WAY-171318Cas No. 287403-39-8
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
Pack SizePriceAvailabilityQuantity
1 mg$35In Stock
5 mg$81In Stock
10 mg$143In Stock
25 mg$238In Stock
50 mg$357In Stock
100 mg$529In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "TMI-1"

Select Batch
Purity:97.36%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
TMI-1 (WAY-171318), a novel orally active inhibitor of ADAM17 (TACE) and MMP, induces tumor apoptosis in a breast cancer.
Targets&IC50
TNF-α secretion (Raw cells):40 nM, ADAM12:1.8 nM(ki), MMP14:26 nM, ADAM17/TACE:8.4 nM (IC50), ADAMTS-4:100 nM, ADAM10:16 nM(ki), MMP13:3 nM, MMP9:12 nM, TNF-α secretion (THP-1 cells):200 nM, ADAM17/TACE:0.079 nM(ki), MMP1:6.6 nM, MMP2:4.7 nM, ADAM8:21 nM(ki), MMP7:26 nM
In vitro
TMI 1 inhibits LPS-induced TNF-α secretion in Raw and THP-1 cells (IC50s = 40 and 200 nM, respectively), as well as in isolated human monocytes and whole blood (IC50s = 190 and 300 nM, respectively).[1]
It inhibits the production of TNF-α ex vivo in synovium isolated from the inflamed joints of patients with rheumatoid arthritis with IC50 values of less than 100 nM without inhibiting TNF-α expression in vitro.[3]
In vivo
TMI 1 inhibits LPS-induced TNF-α production in mice (ED50 = 5 mg/kg) and reduces disease severity in mouse models of collagen-induced arthritis. It also decreases cell viability of (ED50s = 1.3-8.1 μM), and induces caspase-3/7 activity in, a variety of cancer cell lines and induces tumor apoptosis and reduces tumor growth in an MMTV-ErbB2/neu mouse model of breast cancer when administered at a dose of 100 mg/kg.[3]
AliasWAY-171318
Chemical Properties
Molecular Weight398.5
FormulaC17H22N2O5S2
Cas No.287403-39-8
SmilesCC#CCOc1ccc(cc1)S(=O)(=O)N1CCSC(C)(C)[C@@H]1C(=O)NO
Relative Density.1.325 g/cm3 (Predicted)
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 35.9 mg/mL (410.4 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.5094 mL12.5471 mL25.0941 mL125.4705 mL
5 mM0.5019 mL2.5094 mL5.0188 mL25.0941 mL
10 mM0.2509 mL1.2547 mL2.5094 mL12.5471 mL
20 mM0.1255 mL0.6274 mL1.2547 mL6.2735 mL
50 mM0.0502 mL0.2509 mL0.5019 mL2.5094 mL
100 mM0.0251 mL0.1255 mL0.2509 mL1.2547 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy TMI-1 | purchase TMI-1 | TMI-1 cost | order TMI-1 | TMI-1 chemical structure | TMI-1 in vivo | TMI-1 in vitro | TMI-1 formula | TMI-1 molecular weight